Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Clearwater Paper Corp Market Cap
Based on ratings from 1 stock analysts, the Clearwater Paper Corp stock price is expected to increase by 36.38% in 12 months. This is calculated by using the average 12-month stock price forecast for Clearwater Paper Corp. The lowest target is $37 and the highest is $37. Please note analyst price targets are not guaranteed and could be missed completely.
About 1 Wall Street analysts have assignedCLW 1 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Clearwater Paper Corp to buy. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on CLW. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of CLW.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Matthew McKellar RBC Capital | Outperform | $37 | Reiterates | Nov 5, 2024 |
RBC Capital | Outperform | Reiterates | Oct 21, 2024 | |
| Matthew McKellar RBC Capital | Outperform | $37 | Upgrade | Oct 18, 2024 |
| Matthew McKellar RBC Capital | Sector Perform | $48 | Maintains | Aug 7, 2024 |
| Matthew McKellar RBC Capital | Sector Perform | $42 | Maintains | Apr 30, 2024 |
| Matthew McKellar RBC Capital | Sector Perform | Downgrade | Oct 31, 2023 | |
| Paul Quinn RBC Capital | Outperform | $42 | Reiterates | Sep 8, 2023 |
| Paul Quinn RBC Capital | Outperform | $42 | Reiterates | May 3, 2023 |
| Paul Quinn RBC Capital | Outperform | $42 | Upgrade | Apr 24, 2023 |
| Paul Quinn RBC Capital | Sector Perform | $45 | Downgrade | Nov 1, 2022 |
| Mark Wilde BMO Capital | Outperform | $52 | Maintains | Nov 1, 2022 |
| Mark Wilde BMO Capital | Outperform | $47 | Maintains | Aug 4, 2022 |
| Paul Quinn RBC Capital | Outperform | $45 | Upgrade | Aug 3, 2022 |
| Paul Quinn RBC Capital | Sector Perform | $35 | Downgrade | Feb 16, 2022 |
| Mark Wilde BMO Capital | Market Perform | $42 | Downgrade | Dec 20, 2021 |
| Paul Quinn RBC Capital | Outperform | $50 | Upgrade | Oct 20, 2021 |
| Paul Quinn RBC Capital | Sector Perform | $45 | Downgrade | Feb 26, 2021 |
BMO Capital | Outperform | Initiates | Jan 21, 2021 | |
| Matthew Miller CFRA | Strong Buy | $38 | Maintains | May 6, 2020 |
| Paul Quinn RBC Capital | Sector Perform | $20 | Upgrade | Jan 14, 2020 |
When did it IPO
2008
Staff Count
3,100
Country
United States
Sector/Industry
Basic Materials/Paper & Paper Products
CEO
Mr. Arsen S. Kitch
Market Cap
$444.7M
In 2023, CLW generated $2.08B in revenue, which was a increase of 0.13% from the previous year. This can be seen as a signal that CLW's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Mon, 04 Nov 2024
Sentiment - NEUTRAL
Source - Seeking Alpha
Summary - Clearwater Paper Corporation (NYSE: CLW) will host its Q3 2024 earnings conference call on November 4 at 5:00 PM ET, featuring key executives and RBC Capital Markets.
Why It Matters - Clearwater Paper's Q3 earnings call may reveal financial performance and future guidance, impacting stock valuation and investor sentiment.
Mon, 04 Nov 2024
Sentiment - NEUTRAL
Source - Business Wire
Summary - Clearwater Paper Corporation (NYSE: CLW) reported Q3 and nine-month results, noting the sale of its tissue business effective November 1, 2024, with the tissue segment now classified as discontinued operations.
Why It Matters - Clearwater Paper's Q3 results show a shift in focus post-tissue business sale, impacting revenue streams and profitability, crucial for assessing future performance and stock value.
Fri, 01 Nov 2024
Sentiment - NEUTRAL
Source - Business Wire
Summary - Sofidel has acquired Clearwater Paper's tissue division, marking its largest transaction to date. The deal is seen as a strategic move for the company's growth in the hygiene paper market.
Why It Matters - Sofidel's acquisition of Clearwater Paper's tissue division strengthens its market position and growth potential, impacting competitive dynamics and future profitability in the hygiene products sector.
Fri, 01 Nov 2024
Sentiment - NEUTRAL
Source - Business Wire
Summary - Clearwater Paper Corporation has completed the sale of its tissue business to Sofidel America for $1.06 billion in cash, marking a strategic shift towards paperboard packaging products.
Why It Matters - Clearwater Paper's $1.06 billion sale of its tissue business signals a strategic shift, enhancing its focus on paperboard packaging, potentially improving profitability and market positioning.
Wed, 30 Oct 2024
Sentiment - NEUTRAL
Source - Business Wire
Summary - Arsen Kitch, President and CEO, and Sherri Baker, SVP and CFO of a company based in Spokane, will speak at an upcoming conference and hold one-on-one investor meetings.
Why It Matters - The presence of key executives at a conference signals potential insights into company strategy and performance, potentially influencing investor sentiment and stock prices.
Tue, 29 Oct 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Everus Construction Group Inc. (NYSE: ECG) will join the S&P SmallCap 600 on November 1, replacing Clearwater Paper Corp. (NYSE: CLW). The company is being spun off from MDU Resources Group Inc. (NYSE: MDU).
Why It Matters - Everus Construction Group's addition to the S&P SmallCap 600 enhances its visibility and liquidity, potentially attracting more institutional investment, while Clearwater Paper's removal may negatively impact its stock price.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
